{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA090444"
        ],
        "brand_name": [
          "IMIPRAMINE PAMOATE"
        ],
        "generic_name": [
          "IMIPRAMINE PAMOATE"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-314",
          "68180-315",
          "68180-316",
          "68180-317"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "IMIPRAMINE PAMOATE"
        ],
        "rxcui": [
          "835572",
          "835577",
          "835589",
          "835591"
        ],
        "spl_id": [
          "ed1f6e8f-a00b-484e-9431-170fb83ca167"
        ],
        "spl_set_id": [
          "d1dde497-1889-4424-af18-da7ca6459cf3"
        ],
        "package_ndc": [
          "68180-314-06",
          "68180-314-01",
          "68180-315-06",
          "68180-315-01",
          "68180-316-06",
          "68180-316-01",
          "68180-317-06",
          "68180-317-01"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368180314066",
          "0368180316060",
          "0368180315063"
        ],
        "unii": [
          "MC34P30298"
        ]
      },
      "product_type": "Drugs",
      "event_id": "88838",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA.",
      "recall_number": "D-0027-2022",
      "product_description": "Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775  India NDC# 68180-316-06",
      "product_quantity": "1,902 bottles",
      "reason_for_recall": "Out of specification result observed in a dissolution test at the 9-month long term stability time point.",
      "recall_initiation_date": "20211008",
      "center_classification_date": "20211022",
      "termination_date": "20230313",
      "report_date": "20211027",
      "code_info": "lot H002205, exp. date 08/2023"
    }
  ]
}